Multi-omics and immune cells' profiling of COVID-19 patients for ICU admission prediction: in silico analysis and an integrated machine learning-based approach in the framework of Predictive, Preventive, and Personalized Medicine.

Authors:
Zhu K; Chen Z; Xiao Y; Lai D; Wang X and 2 more

Journal:
EPMA J

Publication Year: 2023

DOI:
10.1007/s13167-023-00317-5

PMCID:
PMC9942629

PMID:
36845281

Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"within the geo (gene expression omnibus) dataset (gse157103) we identified 26 noncovid-19 and 100 covid-19 patients with available transcriptome expression matrix demographic and clinical baseline data."

Code Sharing
Evidence found in paper:

"Declarations Ethics approvalNot applicable. Consent to participateNot applicable. Consent for publicationAll authors gave their consent for publication. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was supported by the following funds: Zhejiang University special scientific research fund for COVID-19 prevention and control, (Q.S.); National Natural Science Foundation of China, 82272191 (Q.S.); National Natural Science Foundation of China, 81901989 (D.L.); Natural Science Foundation of Zhejiang Province, LY21H150005 (D.L.); Foundation for The Top-Notch Youth Talent Cultivation Project of Independent Design Project of National Clinical Research Center for Child Health, Q21B0007 (D.L.); Special Fund for the Incubation of Young Clinical Scientist, The Children’s Hospital of Zhejiang University School of Medicine, CHZJU2022YS002 (D.L.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025